{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T18:11:32Z","timestamp":1790964692917,"version":"4.1.0"},"reference-count":61,"publisher":"Wiley","license":[{"start":{"date-parts":[[2023,12,11]],"date-time":"2023-12-11T00:00:00Z","timestamp":1702252800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Endocrinology"],"published-print":{"date-parts":[[2023,12,11]]},"abstract":"<jats:p>The clinical presentation of primary hyperparathyroidism (PHPT) has evolved over the years from a symptomatic disorder to a predominantly asymptomatic condition. Altered vitamin D metabolism seems to play a role in the presentation of PHPT and may exacerbate the severity of disease. The epidemiology of PHPT differs in the developing versus the developed world, where more severe phenotypes occur in regions where vitamin D deficiency is common. Although it has been validated that patients with PHPT should be vitamin D sufficient, the threshold to supplement in relation to the severity of PHPT and the degree of vitamin D deficiency remains controversial. This review will highlight some of the controversy regarding vitamin D deficiency and the different phenotypes of PHPT.<\/jats:p>","DOI":"10.1155\/2023\/1169249","type":"journal-article","created":{"date-parts":[[2023,12,11]],"date-time":"2023-12-11T21:20:10Z","timestamp":1702329610000},"page":"1-8","source":"Crossref","is-referenced-by-count":16,"title":["Vitamin D Deficiency and the Presentation of Primary Hyperparathyroidism: A Mini Review"],"prefix":"10.1155","volume":"2023","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6992-4274","authenticated-orcid":true,"given":"Niharika","family":"Yedla","sequence":"first","affiliation":[{"name":"Department of Endocrinology, Quincy Medical Group, 1025 Maine Street, Quincy, IL 62301, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8202-9768","authenticated-orcid":true,"given":"Hyon","family":"Kim","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Metabolism and Nutrition, Department of Medicine, Rutgers-Robert Wood Johnson Medical School, MEB 374, 1 RWJ Place, New Brunswick, NJ 08903-0019, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anupa","family":"Sharma","sequence":"additional","affiliation":[{"name":"Penn Medicine Princeton Medicine Physicians, 5 Plainsboro Road, Plainsboro, NJ 08536, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangbing","family":"Wang","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Metabolism and Nutrition, Department of Medicine, Rutgers-Robert Wood Johnson Medical School, MEB 374, 1 RWJ Place, New Brunswick, NJ 08903-0019, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1002\/jbmr.4677","article-title":"Workshop on primary, evaluation and management of primary hyperparathyroidism: summary statement and guidelines from the Fifth international Workshop","volume":"37","author":"J. P. Bilezikian","year":"2022","journal-title":"Journal of Bone and Mineral Research"},{"key":"2","doi-asserted-by":"publisher","DOI":"10.1016\/j.beem.2018.09.004"},{"key":"3","doi-asserted-by":"publisher","DOI":"10.1359\/jbmr.07s202"},{"key":"4","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-016-1169-1"},{"key":"5","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/981581"},{"key":"6","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2010-2704"},{"key":"7","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2005.02371.x"},{"key":"8","doi-asserted-by":"publisher","DOI":"10.1007\/bf03344140"},{"key":"9","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2018-01225"},{"key":"10","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2015-2022"},{"key":"11","doi-asserted-by":"publisher","DOI":"10.4248\/br201302005"},{"key":"12","doi-asserted-by":"publisher","DOI":"10.4158\/ep.8.4.266"},{"key":"13","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/6282687"},{"key":"14","doi-asserted-by":"publisher","DOI":"10.20945\/2359-3997000000211"},{"key":"15","doi-asserted-by":"publisher","DOI":"10.1007\/s00774-020-01142-w"},{"key":"16","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-017-1414-2"},{"key":"17","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.1995.tb02043.x"},{"key":"18","doi-asserted-by":"publisher","DOI":"10.1111\/cen.12210"},{"key":"19","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.85.3.6440"},{"key":"20","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-016-0931-8"},{"key":"21","doi-asserted-by":"publisher","DOI":"10.1016\/j.jocd.2012.11.005"},{"key":"22","doi-asserted-by":"publisher","DOI":"10.1016\/s0002-9343(99)00294-6"},{"key":"23","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2010.10.004"},{"key":"24","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2014-1413"},{"key":"25","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2014-1414"},{"key":"26","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2007-1215"},{"key":"27","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2014-3708"},{"key":"28","doi-asserted-by":"publisher","DOI":"10.4158\/ep12371.or"},{"key":"29","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2003-031014"},{"key":"30","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2006-2802"},{"key":"31","doi-asserted-by":"publisher","DOI":"10.1007\/s00774-015-0673-3"},{"key":"32","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/128352"},{"key":"33","doi-asserted-by":"publisher","DOI":"10.1016\/j.beem.2018.09.009"},{"key":"34","doi-asserted-by":"crossref","first-page":"2420","DOI":"10.1210\/jc.2014-4432","article-title":"Is normocalcemic primary hyperparathyroidism harmful or harmless?","volume":"100","author":"G. Chen","year":"2015","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"35","doi-asserted-by":"publisher","DOI":"10.4158\/ep-2019-0325"},{"key":"36","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgaa084"},{"key":"37","doi-asserted-by":"publisher","DOI":"10.1016\/j.eprac.2021.02.019"},{"key":"38","doi-asserted-by":"crossref","first-page":"2990","DOI":"10.1210\/jc.2012-1230","article-title":"Clinical practice guidelines for multiple endocrine neoplasia type 1 (MEN1)","volume":"97","author":"R. V. Thakker","year":"2012","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"39","doi-asserted-by":"publisher","DOI":"10.1359\/jbmr.090304"},{"key":"40","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(85)90340-7"},{"key":"41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mce.2009.08.020","article-title":"Regulation of vitamin D receptor function in MEN1-related parathyroid adenomas","volume":"313","author":"K. M. Dreijerink","year":"2009","journal-title":"Molecular and Cellular Endocrinology"},{"key":"42","doi-asserted-by":"publisher","DOI":"10.4103\/2230-8210.183467"},{"key":"43","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/978-3-319-22542-5_8","article-title":"Primary hyperparathyroidism in MEN2 syndromes","volume":"204","author":"M. Alevizaki","year":"2015","journal-title":"Recent Results in Cancer Research"},{"key":"44","doi-asserted-by":"publisher","DOI":"10.1016\/j.beem.2018.09.010"},{"key":"45","doi-asserted-by":"crossref","first-page":"605","DOI":"10.4158\/EP161604.RA","article-title":"Vitamin D binding protein and 25-hydroxyvitamin D levels: emerging clinical applications","volume":"23","author":"N. K. Jassil","year":"2017","journal-title":"Endocrine Practice"},{"key":"46","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1007\/s12020-016-0974-x","article-title":"Vitamin D status in primary hyperparathyroidism: effect of genetic background","volume":"55","author":"C. Battista","year":"2017","journal-title":"Endocrine"},{"key":"47","doi-asserted-by":"publisher","DOI":"10.4158\/EP161434.OR"},{"key":"48","doi-asserted-by":"crossref","first-page":"171","DOI":"10.3389\/fendo.2019.00171","article-title":"25-Hydroxyvitamin D and vitamin D binding protein levels in patients with primary hyperparathyroidism before and after parathyroidectomy","volume":"10","author":"X. Wang","year":"2019","journal-title":"Frontiers in Endocrinology"},{"key":"49","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-021-01633-1"},{"key":"50","doi-asserted-by":"crossref","first-page":"F8","DOI":"10.1152\/ajprenal.00336.2004","article-title":"Vitamin D","volume":"289","author":"A. S. Dusso","year":"2005","journal-title":"American Journal of Physiology- Renal Physiology"},{"key":"51","doi-asserted-by":"publisher","DOI":"10.1042\/cs0730659"},{"key":"52","doi-asserted-by":"crossref","first-page":"729","DOI":"10.3390\/nu6020729","article-title":"Vitamin D deficiency in India: prevalence, causalities and interventions","volume":"6","author":"A. Gupta","year":"2014","journal-title":"Nutrients"},{"key":"53","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2014-1417"},{"key":"54","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsbmb.2020.105695"},{"key":"55","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1210\/jc.2004-1772","article-title":"Vitamin D repletion in patients with primary hyperparathyroidism and coexistent vitamin D insufficiency","volume":"90","author":"A. Grey","year":"2005","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"56","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1111\/cen.12398","article-title":"Effect of 25 (OH) D replacements in patients with primary hyperparathyroidism (PHPT) and coexistent vitamin D deficiency on serum 25(OH) D, calcium and PTH levels: a meta-analysis and review of literature","volume":"80","author":"V. N. Shah","year":"2014","journal-title":"Clinical Endocrinology"},{"key":"57","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-020-01473-5"},{"key":"58","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1210\/jc.2013-3978","article-title":"Vitamin D treatment in primary hyperparathyroidism: a randomized placebo controlled trial","volume":"99","author":"L. Rolighed","year":"2014","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"59","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-009-9211-1"},{"key":"60","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.4682"},{"key":"61","doi-asserted-by":"publisher","DOI":"10.1308\/rcsann.2021.0078"}],"container-title":["International Journal of Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/downloads.hindawi.com\/journals\/ije\/2023\/1169249.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/downloads.hindawi.com\/journals\/ije\/2023\/1169249.xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/downloads.hindawi.com\/journals\/ije\/2023\/1169249.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,11]],"date-time":"2023-12-11T21:20:20Z","timestamp":1702329620000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.hindawi.com\/journals\/ije\/2023\/1169249\/"}},"subtitle":[],"editor":[{"family":"Jaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2023,12,11]]},"references-count":61,"alternative-id":["1169249","1169249"],"URL":"https:\/\/doi.org\/10.1155\/2023\/1169249","relation":{},"ISSN":["1687-8345","1687-8337"],"issn-type":[{"value":"1687-8345","type":"electronic"},{"value":"1687-8337","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12,11]]}}}